A5091427434- Ovarian cancer diagnosis and treatment
- Reproductive Biology and Fertility
- Breast Cancer Treatment Studies
- Brain Metastases and Treatment
- Endometrial and Cervical Cancer Treatments
- Glioma Diagnosis and Treatment
- BRCA gene mutations in cancer
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Breast Lesions and Carcinomas
- Cervical Cancer and HPV Research
- Cancer and Skin Lesions
- Meningioma and schwannoma management
- Myasthenia Gravis and Thymoma
- Molecular Biology Techniques and Applications
- Gynecological conditions and treatments
- Renal Diseases and Glomerulopathies
- Microtubule and mitosis dynamics
- Eosinophilic Disorders and Syndromes
- Cancer Diagnosis and Treatment
- Cancer Cells and Metastasis
- Sarcoidosis and Beryllium Toxicity Research
- Gastric Cancer Management and Outcomes
- HER2/EGFR in Cancer Research
- Histiocytic Disorders and Treatments
- Lung Cancer Research Studies
Institut Català d'Oncologia
2024
Centre Oscar Lambret
2004-2014
Centre Hospitalier Universitaire de Lille
2004
Hôpital Albert Calmette
1995
Approximately 5% of breast cancer (BC) will develop leptomeningeal metastases (LM) during the course disease. The median overall survival remains limited to several months despite aggressive treatment. We report case a patient with prolonged response bevacizumab (BEV) and vinorelbine as third line treatment LM. A 29-year-old was diagnosed in 2008 an invasive ductal carcinoma negative hormonal receptors overexpressed HER2. She initially received neoadjuvant chemotherapy plus trastuzumab,...
In Leptomeningeal Metastases (LM), short half-life agents administered by the lumbar route do not reach therapeutic ventricular concentrations resulting in negative impact on PFS. Other advantages of intraventricular devices include less painfull procedures, certainty that drug is well delivered. However, only a few studies have reported complications rates and their management. Our aim was to collect prospectively relative implantation use an device consecutive patients diagnosed with LM...
Abstract Background: The incidence of atypical ductal hyperplasia (ADH) is increasing due to mass screening. Because the underestimation risk malignancy, management remains controversial. Our goal was analyze clinicopathologic features patients with ADH diagnosed on directional vacuum-assisted biopsy (DVAB). objectives this continuous retrospective study were evaluate rate malignancy and identify predictors upgrade carcinoma. Methods: Between 2003 2010, 3159 underwent stereotactic DVAB in...